Products

What will AGI do for Aripiprazole?

This classification denotes an antipsychotic agent with the molecular formula C23H27Cl2N3O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 82VFR53I78, chemically known as 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1h)-quinolinone but generally known as aripiprazole, which bears US NIH Compound Identifier 60795. European Medicines Agency schedules Aripiprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05564MIG. The term ARIPIPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 11, No. 11997, List 37). World Health Organization schedules aripiprazole in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule aripiprazole under HS 29337900 and SITC 51561. As of Q4 2014, ARIPIPRAZOLE remains the US FDA Preferred Term for this commodity. Aripiprazole bears US NLM identifiers UMLS ID C0299792 and NCI Concept Code C47403. SMILES: Clc1c(N2CCN(CC2)CCCCOc2cc3NC(=O)CCc3cc2)cccc1Cl.

How AGI delivers it

Four ways AGI delivers for Aripiprazole

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Aripiprazole, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Aripiprazole, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Aripiprazole connects

measured by

  • Active Ingredient Potencymodel
  • Compound Puritymodel
  • Crystal Form Polymorphmodel
  • Residual Solventmodel